# Sun Pharmaceutical Industries Ltd shares are trading flat on Tuesday.

*business · news · 2026-04-28 · Business Today*

## Key points

- Sun Pharma will acquire Organon in an all-cash deal, valuing Organon at $11.75 billion enterprise value.
- The acquisition will transition Sun Pharma from a net cash to a net debt company with about $8 billion debt.
- HDFC Securities expects the deal to be EBITDA accretive by 82% in FY28 for Sun Pharma.
- The Organon deal gives Sun Pharma immediate access to a $691 million biosimilar business and Chinese market strength.
- Post-acquisition, Organon will be delisted from the New York Stock Exchange, likely in early 2027.

**Companies:** Sun Pharmaceutical Industries Ltd
**Countries:** India, United States

[Read the full story on Business Today](https://www.businesstoday.in/markets/stocks/story/buy-sun-pharma-stock-after-organon-deal-hdfc-securities-explains-why-share-price-target-527705-2026-04-28)

---

Canonical: https://newsio.io/n/167a1dea-cfcd-471c-99c3-fe3c1b698a05/sun-pharmaceutical-industries-ltd-shares-are-trading-flat-on-tuesday-the-stock-g
Summarized by Newsio from Business Today. https://newsio.io/how-it-works